Fate Therapeutics, Inc. (FATE)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
77.99+2.29 (+3.03%)
At close: 4:00PM EDT
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 75.70 |
| Open | 78.32 |
| Bid | 77.45 x 800 |
| Ask | 78.50 x 900 |
| Day's Range | 76.18 - 80.80 |
| 52 Week Range | 23.62 - 121.16 |
| Volume | 778,648 |
| Avg. Volume | 1,108,468 |
| Market Cap | 7.314B |
| Beta (5Y Monthly) | 1.67 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.11 |
| Earnings Date | Feb 24, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 113.65 |
- Insider Monkey
Is Fate Therapeutics Stock A Buy or Sell?
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the fourth quarter, which unveil their equity positions as of December 31st. We went through these filings, fixed typos and other more significant errors and identified the changes in hedge fund portfolios. Our extensive […]
- Motley Fool
3 of the Most Innovative Stocks to Buy Now
Here's how shares a diversified e-commerce firm, an immunotherapy biotech, and an electronic agreement company can make you rich.
- Zacks
Fate Therapeutics (FATE) Down 9% Since Last Earnings Report: Can It Rebound?
Fate Therapeutics (FATE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
© 2021 Verizon Media. All rights reserved.
